Milestone Scientific Names Andau Medical as an Additional Distributor for the STA Single Tooth Anesthesia System® in North America

3 years ago

ROSELAND, N.J., Dec. 23, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments,…

TOMI Environmental Solutions Announces Initiation of Equity Analyst Coverage by H.C. Wainwright with a “Buy” Recommendation

3 years ago

FREDERICK, Md., Dec. 23, 2021 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in…

Radius Announces Update on TYMLOS® (abaloparatide) Label

3 years ago

FDA approved the removal of the boxed warning from the TYMLOS label, effective December 22, 2021The boxed warning had referred…

Conformis, Inc. Announces Departure of Chief Legal Officer, Corporate Secretary

3 years ago

BILLERICA, Mass., Dec. 23, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that Brent Alldredge, Chief Legal Officer and Corporate…

Microbot Medical Secures Third Patent for the LIBERTY® Robotic System in the United States; Success of Protecting Novel Intellectual Property Complements Recent Design Freeze Achievement

3 years ago

HINGHAM, Mass., Dec. 23, 2021 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), announced that the United States Patent and…

Femasys Inc. to Participate in Upcoming January Investor Conferences

3 years ago

ATLANTA, Dec. 23, 2021 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women's needs worldwide…

Vallon Pharmaceuticals Announces Achievement of Last Patient Last Visit in Pivotal SEAL Study for Lead Program, ADAIR

3 years ago

- Topline results from pivotal SEAL study expected in Q1 2022 - If approved, ADAIR will target the growing Adderall®…

Codex DNA Expands Catalog of COVID-19 Tools with Release of Full-Length Synthetic Genome for SARS-CoV-2 Omicron Variant

3 years ago

Researchers around the world can utilize the synthetic genome to produce virus to test strain-specific diagnostics, monoclonal antibody treatments, small-molecule…

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

3 years ago

NEW YORK, Dec. 23, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD/LFMDP), a leading direct-to-patient telehealth company, today announced that…

Arcutis Biotherapeutics Secures $225 Million in Non-Dilutive Debt Financing from SLR Capital Partners

3 years ago

WESTLAKE VILLAGE, Calif., Dec. 23, 2021 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing…